Last 23,250 KRW
Change Today +50.00 / 0.22%
Volume 18.1K
011040 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:10 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

kyungdong pharm co ltd (011040) Snapshot

Open
23,450
Previous Close
23,200
Day High
23,600
Day Low
22,750
52 Week High
07/10/14 - 23,850
52 Week Low
11/27/13 - 11,550
Market Cap
308.6B
Average Volume 10 Days
24.3K
EPS TTM
1,596
Shares Outstanding
13.3M
EX-Date
06/27/14
P/E TM
14.6x
Dividend
600.00
Dividend Yield
2.58%
Current Stock Chart for KYUNGDONG PHARM CO LTD (011040)

Related News

No related news articles were found.

kyungdong pharm co ltd (011040) Related Businessweek News

No Related Businessweek News Found

kyungdong pharm co ltd (011040) Details

Kyung Dong Pharmaceutical Co., Ltd. manufactures and sells various medicines. The company offers various prescription medicines in the liver therapy, muscle relaxant, urology, gastrointestinal, neuropathic, antispasmodic, antimigrain, antibacterial, antihistamine, osteoporosis, antidiabetic, vitamin, cardiovascular, CNS, respiratory, antiviral, antifungal, pain/inflammation, antiobesity, and allergy areas. It also provides OTC drugs in the pain/inflammation, respiratory, antihistamine, antiinflammatory enzyme, antiviral, cardiovascular, and gastrointestinal areas, as well as offers a range of APIs. Kyung Dong Pharmaceutical Co., Ltd. sells its products in South Korea, as well as exports to Japan, China, Southeast Asia, and Central and Southern America. The company was formerly known as Yuil Trading Company and changed its name to Kyung Dong Pharmaceutical Co., Ltd. in February 1976. Kyung Dong Pharmaceutical Co., Ltd. was founded in 1975 and is headquartered in Seoul, South Korea.

Founded in 1975

kyungdong pharm co ltd (011040) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kyungdong pharm co ltd (011040) Key Developments

Kyung Dong Pharmaceutical Co., Ltd., Annual General Meeting, Mar 21, 2014

Kyung Dong Pharmaceutical Co., Ltd., Annual General Meeting, Mar 21, 2014., at 10:00 Korea Standard Time. Location: auditorium yanggammyeon. Agenda: To consider the approval of the financial statements; to consider the election of directors; to consider election of audit; and to consider approval of the director remuneration.

Kyung Dong Pharmaceutical Co., Ltd., Annual General Meeting, Mar 22, 2013

Kyung Dong Pharmaceutical Co., Ltd., Annual General Meeting, Mar 22, 2013., at 10:00 Korea Standard Time. Location: Hwaseong-si, Gyeonggi-do yanggammyeon daeyangri 535-3 headquarters auditorium. Agenda: To consider financial statements, balance sheet, income statement and statement of appropriation of retained earnings (not) approved; to consider incorporation of some changes; to consider election of directors; to consider audit appointment; and to consider approval of the audit fees limit.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
011040:KS 23,250.00 KRW +50.00

011040 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 011040.
View Industry Companies
 

Industry Analysis

011040

Industry Average

Valuation 011040 Industry Range
Price/Earnings 11.5x
Price/Sales 2.0x
Price/Book 1.7x
Price/Cash Flow 12.8x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KYUNGDONG PHARM CO LTD, please visit www.kdpharma.co.kr/english. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.